2017 Q3 Form 10-Q Financial Statement
#000143774917015699 Filed on September 07, 2017
Income Statement
| Concept | 2017 Q3 | 2017 Q2 | 2016 Q3 |
|---|---|---|---|
| Revenue | $195.0K | $250.0K | $202.0K |
| YoY Change | -3.47% | 150.0% | 91.17% |
| Cost Of Revenue | $217.0K | $320.0K | $127.0K |
| YoY Change | 70.87% | 433.33% | 20.19% |
| Gross Profit | -$22.00K | -$70.00K | $75.00K |
| YoY Change | -129.33% | -275.0% | |
| Gross Profit Margin | -11.28% | -28.0% | 37.13% |
| Selling, General & Admin | $1.641M | $1.700M | $1.519M |
| YoY Change | 8.03% | 27.82% | -20.34% |
| % of Gross Profit | 2025.33% | ||
| Research & Development | $1.102M | $1.140M | $1.636M |
| YoY Change | -32.64% | -30.49% | -34.11% |
| % of Gross Profit | 2181.33% | ||
| Depreciation & Amortization | $31.00K | $40.00K | $34.00K |
| YoY Change | -8.82% | 33.33% | 19.11% |
| % of Gross Profit | 45.33% | ||
| Operating Expenses | $2.743M | $2.840M | $3.155M |
| YoY Change | -13.06% | -4.38% | -28.13% |
| Operating Profit | -$2.765M | -$2.910M | -$3.080M |
| YoY Change | -10.23% | -0.68% | -29.84% |
| Interest Expense | $100.0K | $340.0K | -$750.0K |
| YoY Change | -113.33% | 580.0% | -3850.0% |
| % of Operating Profit | |||
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | -$2.660M | -$2.580M | -$3.830M |
| YoY Change | -30.55% | -35.18% | -6.81% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$2.663M | -$2.580M | -$3.827M |
| YoY Change | -30.42% | -35.18% | -8.04% |
| Net Earnings / Revenue | -1365.64% | -1032.0% | -1894.78% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$4.361M | -$3.035M | -$34.82M |
| COMMON SHARES | |||
| Basic Shares Outstanding | |||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2017 Q3 | 2017 Q2 | 2016 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $11.40M | $8.400M | $9.100M |
| YoY Change | 25.27% | 23.53% | -35.92% |
| Cash & Equivalents | $11.41M | $8.421M | $9.025M |
| Short-Term Investments | $0.00 | $0.00 | $100.0K |
| Other Short-Term Assets | $383.0K | $622.0K | $461.5K |
| YoY Change | -17.01% | 431.62% | 9.23% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $86.00K | $48.00K | $150.0K |
| Other Receivables | $400.0K | $0.00 | $2.500M |
| Total Short-Term Assets | $12.78M | $9.746M | $12.55M |
| YoY Change | 1.83% | -0.13% | -17.87% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $146.0K | $170.0K | $248.1K |
| YoY Change | -41.15% | -37.73% | 1.44% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $3.000K | $3.000K | $324.1K |
| YoY Change | -99.07% | -99.06% | -6.87% |
| Total Long-Term Assets | $303.0K | $327.0K | $572.2K |
| YoY Change | -47.05% | -44.76% | -7.35% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $12.78M | $9.746M | $12.55M |
| Total Long-Term Assets | $303.0K | $327.0K | $572.2K |
| Total Assets | $13.09M | $10.07M | $13.13M |
| YoY Change | -0.31% | -2.69% | -17.46% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $183.0K | $586.0K | $639.8K |
| YoY Change | -71.4% | 57.1% | 98.9% |
| Accrued Expenses | $1.530M | $3.059M | $3.381M |
| YoY Change | -54.75% | 14.36% | -6.76% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | $0.00 | $25.00K |
| YoY Change | -100.0% | -100.0% | -75.0% |
| Total Short-Term Liabilities | $2.985M | $4.603M | $9.148M |
| YoY Change | -67.37% | -25.37% | 126.0% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | |
| YoY Change | |||
| Other Long-Term Liabilities | $600.0K | ||
| YoY Change | 0.0% | ||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $2.985M | $4.603M | $9.148M |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $2.999M | $4.626M | $9.792M |
| YoY Change | -69.37% | -32.2% | 109.56% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$190.0M | -$187.4M | -$181.7M |
| YoY Change | 4.59% | 5.33% | 7.57% |
| Common Stock | $200.6M | $193.2M | $185.3M |
| YoY Change | 8.21% | 6.37% | 2.43% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $295.0K | $263.0K | $141.9K |
| YoY Change | 107.91% | 90.58% | 7.19% |
| Treasury Stock Shares | $70.08K | $48.07K | $7.341K |
| Shareholders Equity | $10.10M | $5.400M | $3.300M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $13.09M | $10.07M | $13.13M |
| YoY Change | -0.31% | -2.69% | -17.46% |
Cashflow Statement
| Concept | 2017 Q3 | 2017 Q2 | 2016 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$2.663M | -$2.580M | -$3.827M |
| YoY Change | -30.42% | -35.18% | -8.04% |
| Depreciation, Depletion And Amortization | $31.00K | $40.00K | $34.00K |
| YoY Change | -8.82% | 33.33% | 19.11% |
| Cash From Operating Activities | -$4.238M | -$2.490M | -$2.921M |
| YoY Change | 45.09% | -12.63% | -6.33% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$10.00K | -$20.00K | $0.00 |
| YoY Change | -100.0% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | -$190.0K | $10.00K |
| YoY Change | -100.0% | -90.0% | |
| Cash From Investing Activities | -$12.00K | -$210.0K | -$30.00K |
| YoY Change | -60.0% | -132.22% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | -$7.189M | $4.000K | |
| YoY Change | -179825.0% | 1026.76% | |
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 7.180M | -10.00K | 5.225M |
| YoY Change | 37.42% | -111.11% | -20707.38% |
| NET CHANGE | |||
| Cash From Operating Activities | -4.238M | -2.490M | -2.921M |
| Cash From Investing Activities | -12.00K | -210.0K | -30.00K |
| Cash From Financing Activities | 7.180M | -10.00K | 5.225M |
| Net Change In Cash | 3.020M | -2.710M | 2.261M |
| YoY Change | 33.57% | -1.81% | -174.12% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$4.238M | -$2.490M | -$2.921M |
| Capital Expenditures | -$10.00K | -$20.00K | $0.00 |
| Free Cash Flow | -$4.228M | -$2.470M | -$2.921M |
| YoY Change | 44.74% | -13.33% | -6.03% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3000 | |
| CY2017Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
22000 | |
| CY2016Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-31000 | |
| CY2001Q2 | optt |
Deferred Credits Payable Market Discount Rate
DeferredCreditsPayableMarketDiscountRate
|
0.3 | |
| CY2001Q2 | optt |
Deferred Credits Payable Market Liquidated Damages Rate
DeferredCreditsPayableMarketLiquidatedDamagesRate
|
0.3 | |
| CY2001Q2 | optt |
Deferred Credits Payable Option Details
DeferredCreditsPayableOptionDetails
|
500000 | |
| CY2017Q3 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
14000 | |
| CY2017Q2 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
23000 | |
| CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11414000 | |
| CY2017Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8421000 | |
| CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | |
| CY2017Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | |
| CY2016Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
218000 | |
| CY2017Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
701977 | |
| CY2017Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
8909000 | |
| CY2016Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7030000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
370000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
-133000 | |
| CY2017Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11929000 | |
| CY2016Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9291000 | |
| CY2017Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
3020000 | |
| CY2016Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
2261000 | |
| CY2017Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2016Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
711453 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
13000 | |
| CY2017Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q3 | us-gaap |
Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
|
350000 | |
| CY2017Q2 | us-gaap |
Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
|
||
| CY2017Q3 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
3000 | |
| CY2016Q3 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
||
| CY2017Q3 | us-gaap |
Interest Paid
InterestPaid
|
1000 | |
| CY2017Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
12621205 | |
| CY2017Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6313996 | |
| CY2017Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
13000 | |
| CY2017Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
6000 | |
| CY2017Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-2641000 | |
| CY2016Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-3858000 | |
| CY2017Q3 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(h) Concentration of Credit Risk</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company's consolidated revenues for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the periods indicated:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Customer </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mitsui Engineering & Shipbuilding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; MARGIN-TOP: 0px; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">U.S. Department of Defense Office of Naval Research</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require its customers to maintain collateral.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> | |
| CY2016Q3 | us-gaap |
Interest Paid
InterestPaid
|
2000 | |
| CY2017Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
91000 | |
| CY2017Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
91000 | |
| CY2017Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
622000 | |
| CY2017Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3000 | |
| CY2017Q3 | us-gaap |
Construction Payable Current
ConstructionPayableCurrent
|
46000 | |
| CY2017Q2 | us-gaap |
Construction Payable Current
ConstructionPayableCurrent
|
898000 | |
| CY2017Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
217000 | |
| CY2016Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
127000 | |
| CY2017Q3 | us-gaap |
Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
|
||
| CY2017Q2 | us-gaap |
Customer Advances And Deposits Current
CustomerAdvancesAndDepositsCurrent
|
600000 | |
| CY2017 | optt |
Number Of Financing Agreements Closed
NumberOfFinancingAgreementsClosed
|
4 | |
| CY2017Q3 | optt |
Number Of Financing Agreements Closed
NumberOfFinancingAgreementsClosed
|
4 | |
| CY2017Q3 | us-gaap |
Customer Advances And Deposits Current
CustomerAdvancesAndDepositsCurrent
|
600000 | |
| CY2001Q2 | us-gaap |
Customer Advances Or Deposits Noncurrent
CustomerAdvancesOrDepositsNoncurrent
|
600000 | |
| CY2017Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
31000 | |
| CY2016Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
34000 | |
| CY2017Q3 | optt |
Warrant Liability Current
WarrantLiabilityCurrent
|
286000 | |
| CY2017Q2 | optt |
Warrant Liability Current
WarrantLiabilityCurrent
|
323000 | |
| CY2017Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
183000 | |
| CY2017Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
586000 | |
| CY2017Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
86000 | |
| CY2017Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
48000 | |
| CY2017Q3 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
132000 | |
| CY2017Q2 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
132000 | |
| CY2017Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1530000 | |
| CY2017Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3059000 | |
| CY2017Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
358000 | |
| CY2017Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
478000 | |
| CY2017Q3 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
420000 | |
| CY2017Q2 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
484000 | |
| CY2017Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-138000 | |
| CY2017Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-160000 | |
| CY2017Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
200549000 | |
| CY2017Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
193234000 | |
| CY2017Q3 | us-gaap |
Assets
Assets
|
13085000 | |
| CY2017Q2 | us-gaap |
Assets
Assets
|
10073000 | |
| CY2017Q3 | us-gaap |
Assets Current
AssetsCurrent
|
12782000 | |
| CY2017Q2 | us-gaap |
Assets Current
AssetsCurrent
|
9746000 | |
| CY2017Q3 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
36000 | |
| CY2017Q2 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
35000 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.22 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.72 | |
| CY2017Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
90000 | |
| CY2016Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-13000 | |
| CY2017Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-37000 | |
| CY2016Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
752000 | |
| CY2017Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
62000 | |
| CY2016Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
5000 | |
| CY2017Q3 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-4000 | |
| CY2016Q3 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
||
| CY2017Q3 | us-gaap |
Gross Profit
GrossProfit
|
-22000 | |
| CY2016Q3 | us-gaap |
Gross Profit
GrossProfit
|
75000 | |
| CY2017Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-405000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
264000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
38000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
150000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1531000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
215000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
||
| CY2016Q3 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-39000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-239000 | |
| CY2017Q3 | us-gaap |
Liabilities
Liabilities
|
2999000 | |
| CY2017Q2 | us-gaap |
Liabilities
Liabilities
|
4626000 | |
| CY2017Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13085000 | |
| CY2017Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10073000 | |
| CY2017Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2985000 | |
| CY2017Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4603000 | |
| CY2017Q3 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
350000 | |
| CY2017Q2 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
||
| CY2017Q3 | us-gaap |
Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
|
298000 | |
| CY2017Q2 | us-gaap |
Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
|
238000 | |
| CY2017Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
25000 | |
| CY2017Q2 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
25000 | |
| CY2016Q2 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
25000 | |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
7180000 | |
| CY2016Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5225000 | |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-12000 | |
| CY2016Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-30000 | |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4238000 | |
| CY2016Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2921000 | |
| CY2017Q3 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2017Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2743000 | |
| CY2016Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
3155000 | |
| CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2765000 | |
| CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3080000 | |
| CY2017Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
134000 | |
| CY2017Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
186000 | |
| CY2017Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
383000 | |
| CY2017Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
22000 | |
| CY2017Q3 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
142000 | |
| CY2017Q2 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
643000 | |
| CY2017Q3 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
32000 | |
| CY2016Q3 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
4000 | |
| CY2017Q3 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
12000 | |
| CY2016Q3 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
5000 | |
| CY2017Q3 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
||
| CY2016Q3 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
25000 | |
| CY2017Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
| CY2017Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2017Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2017Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2017Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2017Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2017Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
7221000 | |
| CY2016Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
||
| CY2017Q3 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
||
| CY2016Q3 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
5261000 | |
| CY2017Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2663000 | |
| CY2016Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-3827000 | |
| CY2017Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
146000 | |
| CY2017Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
170000 | |
| CY2017Q3 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
||
| CY2016Q3 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
32000 | |
| CY2017Q3 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
9000 | |
| CY2016Q3 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
||
| CY2017Q3 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
1102000 | |
| CY2016Q3 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
1636000 | |
| CY2017Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
515000 | |
| CY2017Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
488000 | |
| CY2017Q3 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
361000 | |
| CY2017Q2 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
334000 | |
| CY2017Q3 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
154000 | |
| CY2017Q2 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
154000 | |
| CY2017Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-190043000 | |
| CY2017Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-187370000 | |
| CY2017Q3 | us-gaap |
Revenues
Revenues
|
195000 | |
| CY2016Q3 | us-gaap |
Revenues
Revenues
|
202000 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
| CY2017Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1641000 | |
| CY2016Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1519000 | |
| CY2017Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
91000 | |
| CY2016Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
218000 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
128641 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
16.10 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
161.18 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
6910 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
||
| CY2016Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.10 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
5000 | |
| CY2017Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
237214 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
230304 | |
| CY2017Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
14.64 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
10.24 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
| CY2017Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
4000 | |
| CY2017Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y109D | |
| CY2017Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
100323 | |
| CY2017Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y219D | |
| CY2017Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P9Y73D | |
| CY2017Q3 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
||
| CY2017Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
7221000 | |
| CY2017Q3 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
||
| CY2017Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
10086000 | |
| CY2017Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
5447000 | |
| CY2017Q3 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
70081 | |
| CY2017Q2 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
48065 | |
| CY2017Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
295000 | |
| CY2017Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
263000 | |
| CY2017Q3 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
32000 | |
| CY2017Q3 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
163000 | |
| CY2017Q2 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
296000 | |
| CY2017Q3 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2017Q3 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b) Use of Estimates</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The current economic environment, particularly the macroeconomic pressures in certain European countries, has increased the degree of uncertainty inherent in those estimates and assumptions.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> | |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
12268683000 | |
| CY2016Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2228585000 |
